Several studies have demonstrated the expression of IL1Ra to be positively correlated with progression and lymph node metastasis (47–49), inhibit IL-1 mediated prostate cancer regression (50), and increased growth rate of glioblastoma cells (51). Here, IL1A is linked to prostate carcinoma.